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Abstract
Nowadays it is observed the wide prevalence of polypous rhinosinusitis, associated with intolerance to aspirin. From today 
positions the main principle of pathogenesis is in presence of “genetic block” of constitutive cyclooxigenase – the node enzyme of 
metabolism of arachidonic acid that leads to its active accumulation. It leads to the disorder of lipid metabolism and conditions the 
necessity to study its biochemical features. 
Aim of research. To study biochemical parameters of the lipid exchange in patients with chronic polypous rhinosinusitis, 
associated with intolerance to acetylsalicylic acid by determination of the main metabolites. 
Materials and methods. The results of laboratory examination of 20 patients with aspirin associated polypous rhinosinusitis 
are presented in the article. The control group included 7 practically healthy donors. There were studied the level of arachidonic acid 
in condensate of exhaled air, arachidonic, linoleic, eicosapentaenoic acids, phospholipids, malonic dialdehyde and oxide modification 
of protein in the blood serum. 
Results. There were determined the changes of lipid exchange, which essence is in increase of the level of arachidonic acid 
in condensate of exhaled air and blood serum that leads to the decrease of the content of its main predecessors – linoleic and eicos-
apentaenoic acids and also phospholipids. The increase of arachidonic acid content stimulates the processes of peroxidation and leads 
to the increase of malonic dialdehyde content and oxide modifications of protein. The features of biochemical disorders testify to the 
proinflammatory direction of lipids metabolism. 
Conclusions. The received data confirm the hypothesis of “genetic block” of arachidonic acid metabolism as the main patho-
genetic link of polypous rhinosinusitis, associated with intolerance to aspirin, and allow clearly interpret the clinical image and the 
features of clinical course. 
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1. Introduction 
The problem of pathogenesis, diagnostics and treatment of chronic polypous rhinosinusitis 
(CPRS) gained the special acuteness in last decades and became the one of topical problems of the 
modern medicine, both Ukrainian and European ones [1, 2]. This group of diseases that is related to the 
fast spread ones has a tendency to progressive, relapsing course. At the modern stage the conception 
about the inflammatory origin of CRS is generally accepted [3]. From pathogenetic point of view it is 
the chronic relapsing inflammatory disease of the upper respiratory tracts that is attended with diffuse 
infiltration of all mucosa layers by eosinophilic granulocytes, and the lumen of the nasal cavity is filled 
with slime that contains a lot of eosinophils [4]. The inflammatory process remains even at the absence 
of significant clinical manifestations. The chronic RS with polyposis of nose that is characterized with 
eosonophilic inflammation is clinically attended with intolerance to acetylsalicylic acid in 25–65 % of 
cases [5, 6]. The nose polyps take place in 40–80 % of patients with hypersensitivity to aspirin, and 
hypersensitivity takes place in 15–49 % of patients with polyposis the aspirin [6, 7]. The frequency 
of intolerance to aspirin in healthy people is 1 % [8]. Hypersensitivity or intolerance to acetylsal-
icylic acid is explained for today by non-immunologic mechanisms, because it is not possible to 
determine the sensitization to this preparation. Taking into account that immunologic (allergic) 
mechanisms of aspirin hypersensitivity are not proved and the causes of disorders of arachidonic 
acid metabolism are not finally explained, they are found for today in taking aspirin and other 
NAIP that lead to the disorder of arachidonic acid (AA) metabolism [9]. That is why this disease is 
defined for today as «Aspirin-Exacerbated Respiratory Disease» that is exacerbation of the chronic 
disease of respiratory tracts, conditioned by aspirin [10]. But even the one dose of aspirin or oth-
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er non-steroidal preparations leads to the abrupt worsening of clinical course of already existent 
pathology, so the disorder of arachidonic acid metabolism with starting of the whole pathogenetic 
chain in patients appears without taking these preparations. That is why the study of mechanisms 
of development of aspirin associated polypous rhinosinusitis is a topical task. 
From the positions of today the understanding of ethiopathogenesis aspirin associated poly-
pous rhinosinusitis is connected with the change of arachidonic acid metabolism and is related to 
the group of metabolic diseases (MD) [10–12]. The principal position of pathogenesis is in pres-
ence of its node link that is genetically determined defect of the main enzyme of unsaturated fatty 
acids metabolism, especially arachidonic one – constitive cyclooxygenase – COG1 [13, 14]. As a 
result of blocked metabolism, arachidonic acid is accumulated in organism [15]. It is known, that 
the high concentrations of the free fatty acids activate NADPH-oxidase by activation of C protein 
kinase and activate the formations of free radicals. They initiate lipid peroxide oxidation (LPO) in 
membranes, development of oxidative stress that is characterized with accumulation of LPO toxic 
products, oxidative modification and injury of molecules of proteins and DNA [16]. At accumu-
lation of hydroperoxides, unsaturated aldehydes, malonic dialdehyde and other toxic products of 
lipid peroxidation there are observed the disorders of metabolic processes: inhibition of activity 
of glycolysis and oxide phosphorylation, synthesis of protein and nucleic acids, disorders of the 
different enzyme processes [16].
Many scientists are agreed that the polypous growth is based on proinflammatory reaction 
in nasal epithelium, provoked by the free radical oxidation [17–19]. But the role of these processes 
in pathogenesis of polypous growth in general and especially in patients with aspirin intolerance 
were not studied systematically and that is why are not finally elucidated [20, 21]. But the necessary 
condition of treatment on the principle of pathogenesis intervention is a deciphering of biochemical 
phenotype of disease that is the information about injured links of metabolism, all biochemical 
mechanisms that favor the development of pathological process. It is naturally, that on this base 
only it is possible to intervene in the disease pathogenesis purposefully. The aforesaid became a 
precondition for this research. 
3. Aim of research
To study the features of lipid metabolism in patients with aspirin associated nasal polyposis 
by determination of the level of the main unsaturated fatty acids and their metabolites. 
4. Materials and methods of research
The research included 20 patients, 24–57 years old (mean age was 45,7±0,85) with diagnosis 
“chronic polypous rhinosinusitis, associated with intolerance to aspirin”, who were on stationary 
treatment in ENT-department of the regional clinical hospital of Inano-Frankivsk city during 2015. 
Control included 7 somatically healthy donors, 20–50 years old (42,4±1,16).
Fatty acid composition of the blood serum was determined by the method of capillary gas-liq-
uid chromatography. Identification of chromatographic peaks was realized using individual standard 
solutions of methyl ethers of the fatty acids. Registration and processing of chromatograms were 
carried out using computer with HP Chem Station software. The content of linoleic (18:2, ω-6), eicos-
apentaenoic (20:5, ω-3) and arachidonic (eicosatetraenoic) (20:4, ω-6) acids fractions was determined.
The collection of condensate of exhaled air for determination of AA level was carried out us-
ing apparatus ECoScreen (Erich JAEGER GmbH). The quantitative levels of arachidonic acid were 
determined by IEA method using test-systems «Uscnscn Lifeife Sciencecience Inc. Wuhan» (USA).
Determination of phospholipids in the blood serum is based on interaction of phosphates 
after mineralization with ammonium molybdate at the presence of eikonogen. Extinction was mea-
sured at 630–690 nm against control on spectrophotometer SP 2000. The standard and control 
samples were set synchronously. Phosphorus concentration was determined by formula: 
The analysis of lipids peroxide oxidation (LPO) products – malonic dialdehyde (MDA) was 
realized on the base of determination of TBA-active products by incubation of samples with thio-
barbituric acid, extraction of the products of reaction by butanol and spectrophotometric detection 
of the colored complex on spectrophotometer SP 2000. 
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The analysis of products of proteins peroxide oxidation – proteins oxidative modifications 
(PPM) is based on interaction of oxidized amino acid remains with 2,4-dinitrophenol hydrazine 
with creation of derivatives that have the typical spectrum of absorption. Aldehyde and ketone de-
rivative of the neutral character were registered at 370 nm and the ones of the main character – at 
430 nm of spectrophotometer SM 2000.
For assessment of the distinctions between groups the univariate disperse analysis was re-
alized with the further use of Tukey criterion of the plural comparisons at the value level 0,05 [22].
5. Results of research
The results of our research demonstrated the reliable increase of the level of arachidonic acid 
in condensate of exhaled air and blood serum in patients with aspirin associated nasal polyposis 
comparing with control (Тable 1). 
Table 1
Level of main metabolites of lipid metabolism 
Metabolite name Control Studied group 
AA in condensate of exhaled air (%) 1,5±0,3 5,0±0,6*
AA in blood serum (%) 4,69±0,27 16,99±0,17*
Linoleic acid (%) 29,63±1,63 18,24±3,2*
Eicosapentaenoic (%) 18,57±1,94 3,26±0,74*
Phospholipids (mmol/l) 3,96±0,08 1,24±0,02*
Malonic dialdehyde (nmol/ml) 2,77±0,26 4,1±0,15*
POM370 (mmol/g of protein) 3,47±0,09 4,93±0,16
*
POM430 (mmol/g of protein) 1,93±0,04 6,81±0,94
*
Note: * – statistically significant difference between groups is present (р<0,05)
In fatty-acid spectrum of condensate of exhaled air in patients with hypersensitivity to as-
pirin its content increases by 5,0±0,6 % comparing with 1,5±0,3 % in control, in blood serum – up 
to 16,99±0,17 % comparing with 4,69±0,27 % in control. The differences between groups are sta-
tistically significant. 
AA metabolic predecessor is linoleic acid. The study of fatty-acid composition of the pa-
tients’ blood serum indicates the reliable decrease of linoleic acid quantity to 18,24±3,2 % com-
paring with 29,63±1,63 % in control (Тable 1). Eicosapentaenoic acid is also predecessor of arachi-
donic or eicosatetraenoic one. It was detected the reliably abrupt decrease of its level in patients of 
studied group to 3,26±0,74 % comparing with 18,57±1,94 % in control (Тable 1).
The membrane phospholipids are the one of main sources of AA in organism. Our studies demon-
strated that in healthy people the level of phospholipids corresponds to the value 3,96±0,08 mmol/l. 
In patients with hypersensitivity to aspirin it is reliably decrease in more than three times that is 
1,24±0,02 mmol/l (Тable 1).
At increase of the level of arachidonic acid the formation of free radicals is activated and the 
intensity of processes of peroxide oxidation or peroxidation of lipids and proteins grows. The LPO 
intensity can be testified by concentration of manolic dialdehyde in the blood serum. According to 
our data, MDA concentration in the blood serum of healthy people is 2,77±0,26 nmol/ml, at aspirin 
associated polypous rhinosinusitis it increases to 4,1±0,15 nmol/ml (Тable 1).
The intensity of proteins peroxidation can be testified by concentration of protein oxidative 
modifications in the blood serum. In healthy people of control group the level of POM products 
(aldehyde and ketone derivatives) in the blood plasma is: POM370 – 3,47±0,09 mmol/g of protein, 
POM430 – 1,93±0,04 mmol/g of protein. Our studies demonstrated the reliable increase of con-
centration of products of proteins oxidative modification in the bloods plasma of patients with 
aspirin associated polypous rhinosinusitis: POM370  – to 4,93±0,16 mmol/g of protein, POM430 – to 
6,81±0,94 mmol/g of protein (Тable 1).
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So, the results of the study of patients with polyposis, associated with intolerance to aspirin, 
demonstrated the abrupt increase (almost in 4 times) of arachidonic acid level in patients, decrease 
of the level of its metabolic predecessors (linoleic and eicosapentaenoic acids), decrease of the free 
phospholipids content. The significant increase of the level of LPO and POM products was observed. 
6. Discussion of the results of research
According to the modern views, the principle position of pathogenesis of aspirin associated 
polypous rhinosinusitis is in genetically determined defect of the node enzyme of arachidonic acid 
metabolism – constitutive cyclooxigenase – COG1 (Fig. 1), [11, 13]. In previous works we proved the 
decrease of COG1 expression in mucosa of nasal cavity and polyps in patients with polypous rhi-
nosinusitis, associated with intolerance to aspirin, using the methods of immunohistochemistry [14].
Fig. 1. Metabolism of arachidonic acid
The decrease of COG1 expression naturally leads to the active accumulation of arachidonic 
acid, because it is a substrate of constitutive COG (Fig. 1). The results of our research demonstrated 
the reliable increase of arachidonic acid level in condensate of exhaled air in patients with polypo-
sis, associated with intolerance to aspirin to 5,0±0,6 % comparing with 1,5±0,3 % in norm and in 
the blood serum to 16,99±0,17 % comparing with 4,69±0,27 % in norm.
The decrease of constitutive COG function and AA accumulation lead to the search for the 
possible “alternate” ways of its metabolism and stimulate all its possible directions. The one of 
most important and early is accumulation of products that do not take part in metabolism that is the 
ones that are higher than “genetic block” (Fig. 1). We elucidated that the increase of AA content 
logically leads to the decrease of the level of predecessors, necessary for its synthesis, especially, 
linoleic acid that is metabolic predecessor of AA of the derivatives of ω-6 class. It was detected 
the reliable decrease of the quantity of linoleic acid to 18,24±3,2 % in patients comparing with 
29,63±1,63 % in control. Eicosapentaenoic acid is in fact also the final predecessor of arachidonic or 
eicosatetraenoic one but of the derivatives of ω-3 class. It was detected the reliable abrupt decrease 
of its level in patients to 3,26±0,74 % comparing with 18,57±1,94 % in control (Table 1).
As it is known, the membrane phospholipids are the one of main sources of AA in organism. 
They are the substrate for phospholipases, especially phospholipase А2 as the result of which action 
AA is released from phospholipids (Fig. 1). Our studies demonstrated that in healthy people the 
phospholipids level corresponds to the value 3,96±0,08 mmol/l. In patients with hypersensitivity to 








cessive accumulation of AA leads, according to the principle of reverse connection, to the decrease 
of phospholipids (predecessors) content in the blood serum and, correspondingly, the decrease of 
activity of processes of its release. 
At the disorder of arachidonic acid metabolism there takes place its inclusion in the other 
metabolic processes, especially free radical ones – lipids peroxide oxidation or peroxidation (LPO) 
by cyclooxigenase way (Fig. 1). The manolic dyaldehyde (MDA) is created in significant quantity, 
its concentration in the blood serum can testify about LPO intensity. According to our data, MDA 
concentration in the blood serum of healthy people is 2,77±0,26 nmol/ml, at aspirin associated 
polypous rhinosinusitis it increases to 4,1±0,15 nmol/ml (Table 1).
The free radical processes manifest their injuring effect not only related to the lipids but also 
to the proteins (Fig. 1). It is known, that all enzymes that provide the infinite diverse link of metabolic 
and regulatory processes are proteins. The products of such reactions are the proteins oxidative modi-
fications (POM). In healthy people the level of POM products (aldehyde and ketone derivatives) in the 
blood plasma is: POM370 – 3,47±0,09 mmol/g of protein, POM430 – 1,93±0,04 mmol/g of protein. Our 
studies demonstrated the reliable increase on concentration of products of proteins oxidative modi-
fication in the bloods plasma of patients with aspirin associated polypous rhinosinusitis: POM370 – to 
4,93±0,16 mmol/g of protein, POM430 – to 6,81±0,94 mmol/g of protein (Table 1).
So, the results of the study of patients with polyposis, associated with intolerance to aspirin, 
demonstrated the abrupt increase (almost in 4 times) of arachidonic acid level in patients, decrease of 
the level of its metabolic predecessors of both derivative of ω-6 – linoleic acid and of ω-3 class – eicos-
apentaenoic one. It was also detected the decrease of free phospholipids content – the main source of AA 
in organism. The significant increase of AA level leads to the activation of free radical processed and 
significant increase of LPO and POM products. 
The high arachidonic acid level and activation of lipids and proteins peroxidation is attend-
ed with accumulation of intermediate and final toxic products that cause metabolic intoxication of 
organism (Fig. 1). The expressed intoxication is typical for the clinical course of aspirin associated 
nasal polyposis [5]. Aggression of free radicals relative to the proteins leads to the change of their 
physical-chemical properties. At that the enzymes can lose their catalytically active groups that lead 
to the disorder of enzyme activity and metabolic processes. Such mechanism can take place at the 
secondary disorder of synthesis of enzymes, responsible for arachidonic acid metabolism (Fig. 1).
Modified proteins are not restored but destructed by proteolytic degradation. At the same 
time it must be taken into account that the decrease of activity of proteolysis enzymes is attended 
with the increase of the level of oxidatively modified proteins in the cell. It favors deceleration of 
proteolysis and apoptosis processes in such cells. As it is known, deceleration of apoptotic death, 
especially of eosinophils is the one of node moments of pathogenesis of productive process at eo-
sinophilic nasal polyposis [4, 6].
7. Conclusions
1. In patients with aspirin associated with aspirin associated polypous rhinosinusitis was 
observed the significant increase of AA content in the blood serum and condensate of exhaled air 
that reliably exceeds the normal indices. 
2. The increase of AA level leads to the decrease of the level of its main metabolic predeces-
sors comparing with control: linoleic, eicosapentaenoic acids and phospholipids. 
3. The activation of “alternate” ways, especially the free radical processes of AA metabo-
lism leads to the growth of malonic dialdehyde, POM370, POM430  comparing with the control group 
as the result of COG1 block. 
4. The revealed biochemical features in patients with aspirin associated polypous rhinosi-
nusitis testify to the proinflammatory directionality of lipids metabolism that is the one of factors 
that favors the continuous-progredient course of disease, development of intoxicating syndrome 
and condition the expedience of the search for the methods of correction. 
5. The revealed changes of lipid metabolism prove the hypothesis of “COG1 genetic block” 
as the main pathogenetic link of aspirin associated polypous rhinosinusitis. 
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